113893-00-8

Basic information

• Product Name: methyl 5-(pyridin-3-yl)pyridine-3-carboxylate
• Synonyms: methyl 5-(pyridin-3-yl)pyridine-3-carboxylate;Methyl [3,3'-bipyridine]-5-carboxylate
• CAS NO: 113893-00-8
• Molecular Formula: C12H10N2O2
• Molecular Weight: 214
• Mol File: 113893-00-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: methyl 5-(pyridin-3-yl)pyridine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 5-(pyridin-3-yl)pyridine-3-carboxylate(113893-00-8)
• EPA Substance Registry System: methyl 5-(pyridin-3-yl)pyridine-3-carboxylate(113893-00-8)

Safety Data

• Hazardous Substances Data: 113893-00-8(Hazardous Substances Data)

Upstream product

• 29681-44-5 5-bromo-3-pyridine carboxylic acid methyl ester 
• 1692-25-7 3-pyridylboronic acid 
• 329214-79-1 3-(4,4,5,5,-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine 

Downstream Products

• 1970-81-6 5-(3-pyridyl)pyridine-3-carboxylic acid 

Relevant articles and documents

NEW COMPOUNDS AND METHODS

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt, solvate, hydrate, tautomer, optical isomer, N-oxide, and/or prodrug thereof. The present invention also relates to pharmaceutical compositions comprising the compounds of the invention, and to their use in the treatment or prevention of medical conditions in which inhibition of c-Abl is beneficial. (I)

HYDROXAMIC ACID DERIVATIVES AS GRAM-NEGATIVE ANTIBACTERIAL AGENTS

The invention relates to chemical compounds of formula (IB): or a salt thereof. In some embodiments, the invention relates to inhibitors of UDP-3-0 — (R-S-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC). In still further embodiments, the invention relates to pharmaceutical compositions comprising compounds disclosed herein and their use in the prevention and/or treatment of Gram- negative bacterial infections.